bpc-157 human evidence randomized clinical trial ππ»ββοΈ Is the lack of data in a red flag? β’ If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury BPC-157 as an Investigational Peptide
Description
Canadian physicians face potential license loss for prescribing it
Doses are tailored
The active peptide degrades silently
We do not recommend it in place of medical treatment for injury or disease
